We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nitric Oxide Found to Be a Factor in Brain Development

By Biotechdaily staff writers
Posted on 05 Aug 2003
Researchers have found that nitric oxide (NO) is a critical regulator of neurogenesis in the developing mammalian brain, a finding that may lead to a new therapeutic approach for replacing lost or injured neurons.

Investigators at Cold Spring Harbor Laboratory (NY, USA) worked with rodents to search for agents that controlled brain development. More...
They established two model systems: in a pharmacological approach, they suppressed NO production in the rat brain by intraventricular infusion of an NO synthase inhibitor; and in a genetic approach, they generated a null mutant neuronal NO synthase knockout mouse line by targeting the exon encoding the active center of the enzyme.

In a paper published July 28, 2003, in the online edition of the Proceedings of the National Academy of Sciences, the researchers reported that in both models the number of new cells generated in neurogenic areas of the adult brain, the olfactory subependyma, and the dentate gyrus, was strongly augmented. This indicates that division of neural stem cells in the adult brain is controlled by NO and suggests a strategy for enhancing neurogenesis in the adult central nervous system.

In conclusion, the authors wrote that their study, "Suggests that modulating nitric oxide levels might be an effective strategy for replacing neurons that are lost from the brain due to stroke or chronic neurodegenerative disorders.”




Related Links:
Cold Spring Harbor Laboratory

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Hematology Consumables
Bioblood Devices
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.